Flag of the European Union EU Clinical Trials Register Help

Clinical trials for asthma

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43871   clinical trials with a EudraCT protocol, of which   7290   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,238 result(s) found for: asthma. Displaying page 1 of 62.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2015-002555-10 Sponsor Protocol Number: ORCA2015 Start Date*: 2015-11-19
    Sponsor Name:Imperial College
    Full Title: Effect of the CRTH2 antagonist OC459 on the response to rhinovirus challenge in asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000015470 10001705 Allergic asthma LLT
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    20.0 100000022885 10049868 Asthma exacerbation prophylaxis LLT
    20.0 100000015470 10003638 Atopic asthma LLT
    20.0 100000015470 10015575 Exacerbation of asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-009556-21 Sponsor Protocol Number: KUH5801112 Start Date*: 2009-03-30
    Sponsor Name:Heikki Koskela
    Full Title: Saline challenge in monitoring asthma control
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003555 Asthma bronchial LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-007240-34 Sponsor Protocol Number: AR010 Start Date*: 2009-04-24
    Sponsor Name:NHS Greater Glasgow & Clyde Hospitals & University of Glasgow
    Full Title: Effect of macrolides on asthma control, airway inflammation and bacterial colonisation in smokers with asthma
    Medical condition: asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    9.1 10003553 Asthma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-002009-22 Sponsor Protocol Number: Inoc 04/03/02 Start Date*: 2006-01-19
    Sponsor Name:VALEAS
    Full Title: CTi-Inoc Study. Compliance to the Inhalatory Therapy - Inoc . Nitric oxide in exhaled air as a marker for monitoring the compliance of therapy with steroid inhalers in asthmatic patients Pilot st...
    Medical condition: Antiasthamatic desease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-007264-41 Sponsor Protocol Number: IAS Start Date*: 2009-02-02
    Sponsor Name:Iho-ja allergiasairaala, HUS
    Full Title: Keuhkoputkien supistumistaipumus 3-6-vuotiailla, hengitystieoireisilla lapsilla
    Medical condition: Tutkimukseen otetaan mukaan kolme lapsiryhmää (3-6v): 1. lapset, jotka lähetetään Iho-ja allergiasairaalaan tutkimuksiin astmaepäilyn vuoksi, 2. lapset, joilla on ollut vauvaiässä hengitystieoireit...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2011-000237-36 Sponsor Protocol Number: 11001 Start Date*: 2011-05-20
    Sponsor Name:University of Nottingham
    Full Title: Predicting Response to Azithromycin Therapy in Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    13.1 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-006576-11 Sponsor Protocol Number: 31318 Start Date*: 2008-06-13
    Sponsor Name:Nottingham University
    Full Title: Macrolides in Refractory Asthma
    Medical condition: Refractory asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-018249-78 Sponsor Protocol Number: 09115 Start Date*: 2010-05-14
    Sponsor Name:University of Nottingham
    Full Title: Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma
    Medical condition: Refractory Asthma
    Disease: Version SOC Term Classification Code Term Level
    12. 10003553 Asthma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-003856-19 Sponsor Protocol Number: LTS12551 Start Date*: 2014-05-28
    Sponsor Name:Sanofi-aventis recherche et développement
    Full Title: Open label extension study to evaluate the long-term safety and tolerability of dupilumab in patients with asthma who participated in previous dupilumab asthma clinical study
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) IT (Completed) PL (Completed) DE (Completed) GB (Completed) NL (Completed) HU (Completed) BE (Completed) DK (Completed) SE (Completed) Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2009-011975-60 Sponsor Protocol Number: AC-060A202 Start Date*: 2010-09-30
    Sponsor Name:Actelion Pharmaceuticals Ltd.
    Full Title: A multi-center, double-blind, placebo-controlled, parallel-group study to establish proof-of-concept and explore the efficacy of different doses of ACT-129968 in adult patients with partly contro...
    Medical condition: Allergic asthma
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10001705 Allergic asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) HU (Completed) PL (Completed) BG (Completed)
    Trial results: View results
    EudraCT Number: 2011-002816-97 Sponsor Protocol Number: ADC3680-04 Start Date*: 2011-09-22
    Sponsor Name:Pulmagen Therapeutics LLP
    Full Title: A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects with Partly Controlled Atopic Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004112-13 Sponsor Protocol Number: 33100 Start Date*: 2009-06-26
    Sponsor Name:Nottingham University
    Full Title: PPAR-gamma: A noval therapeutic target for asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-001572-22 Sponsor Protocol Number: PDY14192 Start Date*: 2015-12-01
    Sponsor Name:SANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT
    Full Title: An exploratory, randomized, double-blind, placebo-controlled study of the effects of dupilumab on airway inflammation of adults with persistent asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) SE (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2007-006664-29 Sponsor Protocol Number: cro955 Start Date*: 2008-02-26
    Sponsor Name:Imperial College
    Full Title: The effect of inhaled corticosteroids (ICS) on airway smooth muscle in asthma
    Medical condition: Asthma is a disease characterised by reversible airways obstruction, bronchial hyper-responsiveness (BHR), and chronic inflammation of the bronchial mucosal lining. Structural changes in the airwa...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-004905-15 Sponsor Protocol Number: 2013103120 Start Date*: 2014-01-22
    Sponsor Name:Respiratory Research Unit, Bispebjerg Hospital
    Full Title: Does asthma phenotype have impact on disease control
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-001928-20 Sponsor Protocol Number: ub004 Start Date*: Information not available in EudraCT
    Sponsor Name:UCB Pharma Belgium
    Full Title: Open-label, multi-centre study to compare the effectiveness of QvarTM Autohaler therapy with conventional therapy (similar doses) in children with stable asthma
    Medical condition: Children aged 7 - 12 with stable mild persistent to moderate persistent asthma (according to the GINA classification)
    Disease: Version SOC Term Classification Code Term Level
    10003553
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-005503-33 Sponsor Protocol Number: CD-RI-CAT-354-1054 Start Date*: 2012-06-04
    Sponsor Name:MedImmune Ltd
    Full Title: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents with Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2004-001072-39 Sponsor Protocol Number: BY9010/M1-142 Start Date*: 2005-02-11
    Sponsor Name:ALTANA Pharma AG
    Full Title: Comparison of Ciclesonide (80 µg Once Daily in the Evening) and Fluticasone propionate (100 µg Twice Daily) in Patients with Mild to Moderate Asthma
    Medical condition: bronchial asthma
    Disease: Version SOC Term Classification Code Term Level
    5.1 10003553 llt
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003074-20 Sponsor Protocol Number: MEN004 Start Date*: 2005-08-17
    Sponsor Name:University of Dundee
    Full Title: Use Of Oral Montelukast As Adjuvant Therapy In The Treatment Of Acute Asthma
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10003553 Asthma LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-002276-27 Sponsor Protocol Number: PVSD-ICS Start Date*: 2016-08-04
    Sponsor Name:Medisch Spectrum Twente
    Full Title: The predictive value of the acute effect of beclomethasone-dipropionate on a mannitol challenge test for the outcome of longterm treatment with beclomethasone-dipropionate in childhood asthma
    Medical condition: exercise induced bronchoconstriction asthma
    Disease: Version SOC Term Classification Code Term Level
    19.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 01 23:58:05 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA